Home
About
Overview
Sharing Data
ORCID
Help
History (1)
G(alpha)12/13 inhibition enhances the anticancer effect of bortezomib through PSMB5 downregulation.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
G(alpha)12/13 inhibition enhances the anticancer effect of bortezomib through PSMB5 downregulation.
G(alpha)12/13 inhibition enhances the anticancer effect of bortezomib through PSMB5 downregulation. Carcinogenesis. 2010 Jul; 31(7):1230-7.
View in:
PubMed
subject areas
Antineoplastic Agents
Antineoplastic Agents
Boronic Acids
Boronic Acids
Bortezomib
Bortezomib
Carcinoma, Hepatocellular
Carcinoma, Hepatocellular
Cell Line
Cell Line
GTP-Binding Protein alpha Subunits, G12-G13
GTP-Binding Protein alpha Subunits, G12-G13
Humans
Humans
In Situ Nick-End Labeling
In Situ Nick-End Labeling
Liver Neoplasms
Liver Neoplasms
Protease Inhibitors
Protease Inhibitors
Proteasome Endopeptidase Complex
Proteasome Endopeptidase Complex
Proteasome Inhibitors
Proteasome Inhibitors
Pyrazines
Pyrazines
RNA, Messenger
RNA, Messenger
authors with profiles
Muralidharan Jayaraman
Danny N Dhanasekaran